Case study: metformin-associated lactic acidosis: could orlistat be relevant?

Trientine for hypertrophic cardiomyopathy: a phase 2 trial.

European heart journal·2026

Predictors of Long-Term Outcomes in Hypertrophic Cardiomyopathy: The NHLBI HCM Registry.

JAMA·2026

Myocardial Fibrosis and Early Intervention in Asymptomatic Patients With Severe Aortic Stenosis: Insights From the EVOLVED Randomized Clinical Trial.

JAMA cardiology·2026

Role of coronary microvascular dysfunction in takotsubo syndrome.

Heart (British Cardiac Society)·2026

Genetic counselling implementation in dilated cardiomyopathy.

European heart journal·2026

Novel cardiovascular metabolic risk factor mechanisms and therapeutic opportunities.

European heart journal·2026

Continuous Glucose Monitoring Metrics and Risks of Severe Hypoglycemia and Diabetic Ketoacidosis in Type 1 Diabetes: A Pooled Analysis.

Diabetes care·2026

The Gain-of-Function GLP1R R131Q Variant Preserves β-Cell Function and Enhances Response to GLP-1 Receptor Agonists.

Diabetes care·2026

Type 2 Diabetes and Longitudinal Changes in Cortical and Trabecular Bone Density, Microarchitecture, and Strength: The Framingham Study.

Diabetes care·2026

In Utero Exposure to Preexisting or Gestational Diabetes Mellitus Increases Incidence of Diabetes in the Children of First Nations and Non-First Nations Mothers: A Retrospective Cohort Study.

Diabetes care·2026

Diagnostic Tools to Establish the Presence of Peripheral Arterial Disease in People With Diabetes (DMPAD): A Multicenter Comparative Diagnostic Accuracy Study.

Diabetes care·2026

Fulminant Secondary HLH Following EBV Reactivation in an Adult With Trisomy 21 After Teplizumab Treatment for Stage 2 Type 1 Diabetes.

Diabetes care·2026

Functional genetic signatures of the gut microbiome in cardiometabolic diseases: mechanisms and translational opportunities.

Frontiers in microbiomes·2026

Prognostic value of the cardiometabolic index for cardiovascular outcomes in patients with type 2 diabetes mellitus.

Frontiers in nutrition·2026

Dynamic Balance of Histone H3 Methylation: Regulatory Mechanisms and Therapeutic Prospects in RA Immune Dysregulation and Bone Metabolism Imbalance.

Journal of immunology research·2026

Non-Invasive Estimation of Systemic Drug Exposure Using Exhaled Breath Metabolomics in Humans: A Translational Proof-of-Concept Study.

Clinical pharmacology and therapeutics·2026

Distinct immunometabolic signatures in peripheral blood mononuclear cells are linked to systemic inflammation in type 2 diabetes and diabetic kidney disease.

Molecular biomedicine·2026

Related Experiment Videos

Case study: metformin-associated lactic acidosis: could orlistat be relevant?

Related Concept Videos

Trientine for hypertrophic cardiomyopathy: a phase 2 trial.

Predictors of Long-Term Outcomes in Hypertrophic Cardiomyopathy: The NHLBI HCM Registry.

Myocardial Fibrosis and Early Intervention in Asymptomatic Patients With Severe Aortic Stenosis: Insights From the EVOLVED Randomized Clinical Trial.

Role of coronary microvascular dysfunction in takotsubo syndrome.

Genetic counselling implementation in dilated cardiomyopathy.

Novel cardiovascular metabolic risk factor mechanisms and therapeutic opportunities.

Continuous Glucose Monitoring Metrics and Risks of Severe Hypoglycemia and Diabetic Ketoacidosis in Type 1 Diabetes: A Pooled Analysis.

The Gain-of-Function GLP1R R131Q Variant Preserves β-Cell Function and Enhances Response to GLP-1 Receptor Agonists.

Type 2 Diabetes and Longitudinal Changes in Cortical and Trabecular Bone Density, Microarchitecture, and Strength: The Framingham Study.

In Utero Exposure to Preexisting or Gestational Diabetes Mellitus Increases Incidence of Diabetes in the Children of First Nations and Non-First Nations Mothers: A Retrospective Cohort Study.

Diagnostic Tools to Establish the Presence of Peripheral Arterial Disease in People With Diabetes (DMPAD): A Multicenter Comparative Diagnostic Accuracy Study.

Fulminant Secondary HLH Following EBV Reactivation in an Adult With Trisomy 21 After Teplizumab Treatment for Stage 2 Type 1 Diabetes.

Functional genetic signatures of the gut microbiome in cardiometabolic diseases: mechanisms and translational opportunities.

Prognostic value of the cardiometabolic index for cardiovascular outcomes in patients with type 2 diabetes mellitus.

Dynamic Balance of Histone H3 Methylation: Regulatory Mechanisms and Therapeutic Prospects in RA Immune Dysregulation and Bone Metabolism Imbalance.

Non-Invasive Estimation of Systemic Drug Exposure Using Exhaled Breath Metabolomics in Humans: A Translational Proof-of-Concept Study.

Distinct immunometabolic signatures in peripheral blood mononuclear cells are linked to systemic inflammation in type 2 diabetes and diabetic kidney disease.

Related Experiment Videos

Case study: metformin-associated lactic acidosis: could orlistat be relevant?

Related Concept Videos

Related Articles